Cryoport, Inc.
corporate_fare Company Profile
Cryoport, Inc. (NASDAQ:CYRX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for CYRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for CYRX spans 10-Q, 4, 8-K, 144.
Recent high-impact activity:
- Cryoport 10-Q Details Q3 Loss, Positive 9-Month Cash Flow and December Note Repayment
- Q3 Revenue Jumps 14% to $50.2M, Guidance Raised to $197-199M
- Cryoport Chief Digital Officer Sells Over $500K in Stock
- Shareholders Approve Significant Increase in Equity Incentive Plan Shares
- Cryoport CFO Sells $2.76 Million in Company Stock
Financial Snapshot
Short Interest & Short Volume
4.14 days to coverFINRA reported short interest of 3,477,459 shares in CYRX as of the October 30, 2026 settlement, a 37.3% increase from the prior period — about 4.1 days to cover at its recent average daily volume. On November 20, 2026, 29.3% of CYRX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.